Abcam plc of CAMBRIDGE, X0, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-08. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Tim James Dye | Director | Cambridge, X0 |
| Jeff Iliffe | Director | Cambridge, X0 |
| Peter James Keen | Director | Cambridge, X0 |
| Tony James Kouzarides | Director | Cambridge, X0 |
| Michael Redmond | Director | Cambridge, X0 |
| David James Warwick | Director | Cambridge, X0 |
| Mark James Webster | Director | Cambridge, X0 |
| Jeff Iliffe | Executive Officer | Cambridge, X0 |
| Michael Redmond | Executive Officer | Cambridge, X0 |
| David James Warwick | Executive Officer | Cambridge, X0 |
| Michael Ross | Director | South San Francisco, CA |
| Peter Vance Allen | Director | Cambridge, X0 |
| Mara Glickman Aspinall | Director | Cambridge, X0 |
| Michael Shaun Baldock | Director | Cambridge, X0 |
| Louise Alexandra Virginia Charlotte Patten | Director | Cambridge, X0 |
| Giles Francis Bertram Kerr | Director | Cambridge, X0 |
| Jonathan Simon Milner | Director | Cambridge, X0 |
| Alan Thomas Hirzel | Director | Cambridge, X0 |
| Peter Keen | Director | Stamford, CT |
| Anthony Martin | Director | Columbus, OH |
| Mike Redmond | Director | Cambridge, X0 |
| Jonathan Milner | Director | Cambridge, X0 |
| Jonathan Milner | Executive Officer | Cambridge, X0 |
| Tony Kouzarides | Director | Cambridge, X0 |
| Murray Hennessy | Director | Cambridge, X0 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-03-12 | D | $800K | $800K |
| 2012-04-27 | D | $77.0M | $77.0M |